本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Avidity Biosciences, Inc.

32.66
-3.5800-9.88%
盘前33.000.3400+1.04%06:04 EDT
成交量:483.12万
成交额:1.60亿
市值:39.37亿
市盈率:-10.79
高:38.00
开:38.00
低:31.59
收:36.24
数据加载中...
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/14

重要事件披露

Form 8-K - Current report
2023/12/13

重要事件披露

Form 8-K - Current report
2023/12/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report